Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole versus ropinirole crossover feasibility trial on memory in non-dementing Parkinson's disease
ISRCTN39374171Phase 4Completed
- Sponsor
- Royal Stoke University Hospital
- Start
- Feb 2013
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of pramipexole and ropinirole in Parkinson's disease (PD), sponsored by Royal Stoke University Hospital. Primary endpoint: Memory performance estimates. Started Feb 2013; status: completed.
02
Drugs
pramipexoleropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ISRCTN39374171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN39374171.